Mutation Clearance after Transplantation for Myelodysplastic Syndrome

BACKGROUND: Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for patients with myelodysplastic syndrome (MDS). The molecular predictors of disease progression after transplantation are unclear. METHODS: We sequenced bone marrow and skin samples from 90 adults with MD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Duncavage, Eric J., Jacoby, Meagan A., Chang, Gue Su, Miller, Christopher A., Edwin, Natasha, Shao, Jin, Elliott, Kevin, Robinson, Joshua, Abel, Haley, Fulton, Robert S., Fronick, Catrina C., O’Laughlin, Michelle, Heath, Sharon E., Brendel, Kimberly, Saba, Raya, Wartman, Lukas D., Christopher, Matthew J., Pusic, Iskra, Welch, John S., Uy, Geoffrey L., Link, Daniel C., DiPersio, John F., Westervelt, Peter, Ley, Timothy J., Trinkaus, Kathryn, Graubert, Timothy A., Walter, Matthew J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309244/
https://ncbi.nlm.nih.gov/pubmed/30207916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1804714
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados